bortezomib - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
BORTEZOMIB ACCORD bortezomib 3.5 mg/1.4 mL solution for injection vial AUST R: 369472Active ingredients:
bortezomib
Dosage form: Injection, solution
Sponsor: Accord Healthcare Pty Ltd
Phone: 1800 222 673
|
From 30 Apr 2025 to 31 Jul 2025
|
Shortage status: Current
Availability: Unavailable
Reason: Manufacturing
Management action: Alternative generic products are available.
|
DBL BORTEZOMIB 2.5 mg powder for injection vial AUST R: 275710Active ingredients:
bortezomib
Dosage form: Injection, powder for
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
Deletion from market:
01 Oct 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: An alternative product is available.
|
DBL Bortezomib bortezomib 1.0 mg powder for injection vial AUST R: 313359Active ingredients:
bortezomib
Dosage form: Injection, powder for
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
Deletion from market:
01 Oct 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: An alternative product is available.
|
VELCADE bortezomib 3.5 mg powder for injection vial AUST R: 104542Active ingredients:
bortezomib
Dosage form: Injection, powder for
Sponsor: Janssen-Cilag Pty Ltd
Phone: 1800226334
|
Deletion from market:
30 Jun 2025
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products are available.
|